In‐hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID‐19) patients and COVID‐19 in mucormycosis: a systematic review and meta‐analysis
Akansha Sinha(UNSW Sydney), Sonu Bhaskar(New South Wales Department of Health)
Cited by 9
Related Papers
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
|Frontiers in Immunology|2020|519
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging
|Particle and Fibre Toxicology|2010|491
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|373